These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26339244)

  • 1. The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes.
    Parise CA; Caggiano V
    J Cancer Epidemiol; 2015; 2015():813456. PubMed ID: 26339244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
    Parise C; Caggiano V
    Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.
    Parise CA; Caggiano V
    BMC Cancer; 2013 Oct; 13():449. PubMed ID: 24083624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
    Parise CA; Bauer KR; Brown MM; Caggiano V
    Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in clinicopatholgic characteristics and risk of mortality between the triple positive and ER+/PR+/HER2- breast cancer subtypes.
    Parise CA; Caggiano V
    Cancer Causes Control; 2019 May; 30(5):417-424. PubMed ID: 30879205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities.
    Parise CA; Caggiano V
    Breast Cancer Res Treat; 2017 May; 163(1):151-158. PubMed ID: 28213780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer Mortality among Asian-American Women in California: Variation according to Ethnicity and Tumor Subtype.
    Parise C; Caggiano V
    J Breast Cancer; 2016 Jun; 19(2):112-21. PubMed ID: 27382386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic status and incidence of breast cancer by hormone receptor subtype.
    Akinyemiju TF; Pisu M; Waterbor JW; Altekruse SF
    Springerplus; 2015; 4():508. PubMed ID: 26405628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis.
    John EM; McGuire V; Kurian AW; Koo J; Shariff-Marco S; Gomez SL; Cheng I; Keegan THM; Kwan ML; Bernstein L; Vigen C; Wu AH
    Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):351-363. PubMed ID: 33355191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors.
    Parise CA; Caggiano V
    Breast Cancer Res Treat; 2017 Oct; 165(3):743-750. PubMed ID: 28689363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes.
    Lawrenson R; Lao C; Campbell I; Harvey V; Seneviratne S; Edwards M; Elwood M; Scott N; Kidd J; Sarfati D; Kuper-Hommel M
    Cancer Causes Control; 2017 Dec; 28(12):1417-1427. PubMed ID: 29027594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers.
    Parise CA; Caggiano V
    J Cancer Epidemiol; 2014; 2014():469251. PubMed ID: 24955090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011).
    Sineshaw HM; Gaudet M; Ward EM; Flanders WD; Desantis C; Lin CC; Jemal A
    Breast Cancer Res Treat; 2014 Jun; 145(3):753-63. PubMed ID: 24794028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional Variation in Disparities in Breast Cancer Specific Mortality Due to Race/Ethnicity, Socioeconomic Status, and Urbanization.
    Parise CA; Caggiano V
    J Racial Ethn Health Disparities; 2017 Aug; 4(4):706-717. PubMed ID: 27604380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.
    Subramaniam S; Bhoo-Pathy N; Taib NA; Tan GH; See MH; Jamaris S; Ho GF; Looi LM; Yip CH
    World J Surg; 2015 Oct; 39(10):2450-8. PubMed ID: 26138872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. a single institution survey spanning 1998 to 2010.
    García Fernández A; Giménez N; Fraile M; González S; Chabrera C; Torras M; González C; Salas A; Barco I; Cirera L; Cambra MJ; Veloso E; Pessarrodona A
    Breast; 2012 Jun; 21(3):366-73. PubMed ID: 22487206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
    Poorolajal J; Nafissi N; Akbari ME; Mahjub H; Esmailnasab N; Babaee E
    Arch Iran Med; 2016 Oct; 19(10):680-686. PubMed ID: 27743431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
    Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
    Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Subtype Variation by Race and Ethnicity in a Diverse Population in British Columbia.
    Wan D; Villa D; Woods R; Yerushalmi R; Gelmon K
    Clin Breast Cancer; 2016 Jun; 16(3):e49-55. PubMed ID: 26454611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study.
    Brown D; Shao S; Jatoi I; Shriver CD; Zhu K
    Cancer Epidemiol; 2016 Jun; 42():24-31. PubMed ID: 26999400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.